Physician profile
Patrick J Lamparello
NPI 1174517908
$2,272.93
in general payments reported to CMS, 2019-2025
17 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $274 · 2021: $271 · 2022: $125 · 2023: $47.83 · 2024: $215 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $661.94 | 2019-2021 | |
| Cook Medical LLC | $550.48 | 2019-2025 | Zenith Alpha |
| Inari Medical, INC. | $265.27 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $143.82 | 2021-2025 | Floseal, Perclot |
| Boston Scientific Corporation | $140.16 | 2019-2024 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $98.32 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $95.00 | 2019 | |
| Penumbra, INC. | $52.53 | 2023-2025 | Penumbra System, Indigo System |
| Medtronic, INC. | $48.73 | 2024-2025 | Inceptiv, Venaseal |
| Cardiovascular Systems INC. | $46.56 | 2020-2021 | |
| Terumo Medical Corporation | $41.79 | 2024 | Azur Cx Detachable, Navicross |
| Pfizer INC. | $36.26 | 2019-2023 | |
| Tactile Systems Technology INC | $23.68 | 2019 | |
| Smith+Nephew, INC. | $22.82 | 2019 | |
| Lemaitre Vascular, INC. | $16.65 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Venclose INC. | $15.78 | 2020 | |
| Kci USA, INC. | $13.14 | 2023 | Prevena, V.A.C. Dermatac, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Lamparello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.